subsets (p<0.001, p<0.001) was decreased in the LSCC patients.
Abstract. CD4
+ regulatory T cells (Tregs) mediate immune tolerance in laryngeal squamous cell carcinoma (LSCC). However, Tregs are functionally heterogeneous. Recently, we reported that three distinct Treg subsets (resting Tregs, activated Tregs and cytokine-secreting CD45RA -Foxp3 low CD4 + T cells) vary in the peripheral circulation of patients with head and neck squamous cell carcinoma (HNSCC); however, the potential implication of these Treg subsets in LSCC immunity is unclear. Here, we report that activated Tregs and cytokine-secreting CD45RA -Foxp3 low CD4 + T cells were increased in LSCC patients compared with healthy donors (HD) (p<0.001, p<0.001), whereas resting Tregs were decreased (p<0.001). Activated Tregs inhibited the proliferation of CD4 + CD25 -T cells (p<0.001) and secreted lower levels of interleukin-2 (p<0.001), interferon-γ (p<0.001) and tumor necrosis factor-α (p<0.001) compared with the cytokinesecreting CD45RA -Foxp3 low CD4 + T cells. Importantly, activated Treg prevalence was correlated with tumor stage (p=0.001) and nodal status (p=0.007). The prevalence of naïve CD4 + (p<0.001), naïve CD8 + (p=0.002), and Th1 T-cell
Introduction
Laryngeal squamous cell carcinoma (LSCC), a common type of head and neck squamous cell carcinoma (HNSCC), accounts for approximately 2.4% of new malignancies worldwide every year (1, 2) . LSCC patients often display considerable variability in survival, despite new advances in treatment (2) .
In the past few years, it has become clear that the complex interaction between LSCC and immune system members plays an important role in determining tumor progression (3) . Among these members, CD4
+ regulatory T cells (Tregs), from either the thymus or the periphery, play an important role in antitumor immune responses, in which they have been associated with suppressive activities against tumor-specific T-cell responses (3, 4) . Several studies have shown that Treg prevalence increases in peripheral blood and many types of human malignancies, such as ovarian, gastric and esophageal cancer (5) (6) (7) (8) (9) .
Despite efforts to better understand the role of Tregs in human malignancies, isolating Treg subsets is difficult due to the lack of Treg-specific markers. Human Tregs with suppressive activities were initially described in 1995 based on elevated CD25 expression (10) . However, subsequent studies showed that these CD4 + CD25 + T cells are mixed populations, composed of suppressor CD4 + CD25 high as well as CD4 + CD25 low T cells, which are nonsuppressive, and activated CD4 + T cells (11) . Until 2003, Foxp3 was thought to be a key transcription factor for the development and function of Tregs (12, 13 Hospital of Sun Yat-Sen University, and was used for research purposes only. Patient and healthy donor (HD) informed consent was obtained before enrollment.
Collection of peripheral blood. Peripheral blood lymphocytes (PbLs) were isolated from peripheral venous blood as we previously described (22). Isolated cells were immediately resuspended in 100 µl flow cytometry staining buffer (ebioscience, San Diego, CA, USA) for surface and intracellular staining.
Antibodies and reagents. Freshly obtained human PbLs were stained with the following anti-human monoclonal antibodies: anti-CD3-eFluor 605NC (0.25 µg/100 µl), anti-CD4-FITC (1.0 µg/100 µl), anti-CD8-PE-Cy7 (0.06 µg/100 µl), anti-CD25-APC (0.125 µg/100 µl) and anti-CD45RA-eFluor 450 (0.5 µg/100 µl) for surface staining; and anti-Foxp3-PE (0.25 µg/100 µl), antitumor necrosis factor-α (TNF-α)-Alexa Fluor 700 (0.25 µg/100 µl), anti-interleukin-2 (IL-2)-PE-Cy7 (0.125 µg/100 µl), anti-interferon-γ (IFN-γ)-APC-eFluor 780 (0.25 µg/100 µl) and anti-interleukin-17 (IL-17)-PerCP-Cy5.5 (0.125 µg/100 µl) for intracellular staining. Soluble anti-CD3 (OKT3, 0.5 µg/ml) and anti-CD28 (CD28.2, 2 µg/ml) mAb were used for in vitro activation of T cells. All antibodies and isotype controls were purchased from ebioscience (San Diego). ++ CD45RA -CD4 + T cells and assessed for their suppressive activity. Soluble anti-CD28 (2 µg/ml) and plate-bound anti-CD3 (0.5 µg/ml) were used to activate T cells in 96-well round-bottom plates, and cells were harvested and analyzed by flow cytometry after 86 h of co-culture. All CFSE data were analyzed using the ModFit software provided by Verity Software House (Topsham, USA). The percentages of suppression were determined based on the proliferation index (PI) of responder cells alone (100% proliferation, 0% suppression) compared with the PI of responders co-cultured (1:1 ratio) with Treg subset.
Statistical analysis. Statistical analysis was performed with SPSS software (SPSS standard version 13.0, IbM, Chicago, IL, USA). Differences between groups were assessed using the Mann-Whitney U test, Student's t-test, or Kruskal-Wallis test. The correlation between Treg subsets and clinical factors (tumor stage and nodal status) was determined by one-way ANOVA. (Fig. 1bb-d ).
Results

Distinct
Suppressive and secretory functions of distinct Treg subsets.
The suppressive activity of each Treg subset from the LSCC patients (n=6) was assessed by their ability to suppress the proliferation of an autologous T-cell population (CD25 (Fig. 1C) . Moreover, the functional cytokine patterns in sorted Treg subsets from 5 LSCC patients were also studied after ex vivo stimulation. Those results suggested that cytokine-secreting CD45RA -Foxp3 low CD4 + T cells secreted significantly higher amounts of IL-2, IFN-γ and TNF-α than did the activated or resting Tregs (p<0.001), whereas IL-17 production remained the same (p>0.05) (Fig. 1D) . (Fig. 4A and b) .
Frequency of
To understand which Th1 subsets varied in LSCC patients, Th1 cells were separated into two subsets (IFN-γ + IL-2 + and IFN-γ + IL-2 -) using our previously described method (28 (Fig. 4C and D) .
Relationship between circulating Treg subsets and clinical variables.
Glottic squamous cell carcinoma is a common type of LSCC, and lymph node metastasis is uncommon in patients with glottic squamous cell carcinoma (especially in patients with T 1 to early T 3 ) due to the lack of lymphatic drainage in the glottic region. In the present study, 37 of the 42 LSCC patients had glottic squamous cell carcinoma; only 7 patients had nodal involvement. Thus, any conclusions regarding the difference between the two populations (N 0 and N + ) must not be overstated since the number of patients in each category was unbalanced (i.e. 35 vs. 7).
The clinical impact of circulating Treg subsets on tumor stage and nodal status was examined. First, the percentage of Tregs was higher in 20 T 3-4 patients (9.07±1.01%) than in 22 T 1-2 patients (7.84±1.28%, p=0.002) and 21 HD (6.37±1.30%, p<0.001) (Fig. 5Aa) . Furthermore, Tregs were increased in 7 N + patients (9.39±0.98%) when compared with Tregs in 35 N 0 patients (8.23±1.28%, p=0.03) and 21 HD (6.37±1.30%, p<0.001) (Fig. 5ba) .
We also aimed to ascertain whether activated Tregs correlated with tumor progression. Interestingly, activated Tregs were elevated in T 3-4 patients (2.80±0.70%) relative to T 1-2 patients (2.18±0.67%, p=0.001) and HD (0.79±0.26%, p<0.001) (Fig. 5Ab) . In addition, activated Tregs were elevated in N + patients (3.05±0.88%) relative to N 0 patients (2.36±0.67%, p=0.007) and HD (0.79±0.26%, p<0.001) (Fig. 5bb) . The percentage of resting Tregs did not differ between patients with T 3-4 and T 1-2 (0.58±0.17% vs. 0.61±0.29%, p=0.90) (Fig. 5Ac) or with N + and N 0 (0.46±0.14% vs. 0.62±0.24%, p=0.58) (Fig. 5bc) . Cytokine-secreting CD45RA -Foxp3 low CD4 + T cells were elevated in T 3-4 patients compared with T 1-2 patients (5.69±0.82% vs. 5.06±0.95%, p=0.02) (Fig. 5Ad) , but did not differ between N + and N 0 patients (5.88±0.52% vs. 5.25±0.97%, p=0.087) (Fig. 5bd) .
Discussion
There is mounting evidence that Tregs are involved in the control of immune regulation in many types of human malignancies, with a particular focus on T-cell suppression (5-9). Tregs have been reported to be negative prognostic factors for ovarian (5), hepatocellular (6), gastric and esophageal cancer (7). However, in contrast to these observations, Pretscher et al showed that higher Treg levels did not show any significant influence on the outcome of oro-and hypopharyngeal carcinoma patients (8) .
In addition, HNSCC studies indicate that elevated Treg levels are prognostic factors and predict better locoregional control and overall survival (9) . This apparent contradiction regarding the role of Tregs in cancer prognosis might be explained by the functional heterogeneity of Tregs. For example, Zhou et al showed that CD4 + Foxp3 -T cells transiently express lower levels of Foxp3, leading to the generation of T cells with a pathogenic memory (29). Allan et al postulated that activated CD4 + T cells express Foxp3, but lack regulatory activity (30). Hence, identification of distinct Treg subsets and their functional abilities might be intriguing for the antitumor immunity field.
Despite a number of studies performed on the role of Tregs in LSCC (15, 23, 31, 32) , the characteristics of functionally distinct Treg subsets in LSCC are poorly understood. Recently, one functional study reported by Drennan et al (15) , showed that suppressive activities of CD127 low/-Tregs (including CD4 + CD25 inter CD127 low/-and CD4 + CD25 high CD127 low/-Tregs) increased in the peripheral circulation of laryngeal and oropharyngeal patients. The decrease was associated with advanced stage and nodal involvement, supporting the need to delineate the prevalence and function of different Treg subsets in LSCC, requiring further assessment of immunotherapeutic strategies. Hence, we sought to analyze the percentage and function of three distinct Treg subsets in LSCC patients at the time of diagnosis. Tregs were significantly higher in LSCC patients than in healthy age-matched donors, in agreement with previous studies (23,31,32). Nonetheless, a new finding was that the percentage of activated Tregs with highly suppressive activities increased in LSCC patients, and that this correlated with tumor stage and nodal status. Although resting Tregs also showed highly suppressive activities, the percentage of this Treg subset decreased, suggesting that resting Tregs may be swiftly converted into activated Tregs immediately after migrating from the thymus or having been peripherally generated (16) .
Another interesting finding of the present study is that cytokine-secreting CD45RA -Foxp3 low CD4 + T cells increased in parallel with activated Tregs. We found that this Treg subset secreted elevated levels of effector cytokines, but did not have suppressive function in vitro. It may be that cytokine-secreting CD45RA -Foxp3 low CD4 + T cells are an heterogeneous Treg subset specific to LSCC. They might also be non-Tregs that differentiate into effector T cells, as others have proposed (16 
